Topic resource collection
Approved comparison material connected to this topic.
479 resourcesRead both sides
BPC-157 Promotes angiogenesis, modulates NF-κB inflammation signaling, accelerates collagen synthesis in tendons and ligaments Rodent tendon injury models showed 40–60% faster healing; human data limited to case reports 200–500 m…
BPC-157 VEGF upregulation, angiogenesis, FAK-paxillin activation Proliferative (weeks 2–8) Rat MCL and Achilles models show 30–40% faster healing, improved tensile strength 10 mcg/kg daily, local or systemic Strongest preclinical…
The table below compares the three peptides with the strongest published evidence for NASH-specific mechanisms. Including their primary pathway of action, documented effects in preclinical models, typical dosing ranges, and the e…
Not all peptides that claim to support DNA integrity work the same way. Some activate repair enzymes directly. Others reduce the damage load by suppressing upstream stressors. Others still enhance immune clearance of cells that h…
Thymalin Thymus / Immune System Restores thymic peptide output; normalizes T-cell differentiation and reduces systemic inflammation Preclinical + observational human studies Subcutaneous injection Requires sustained use (14–21 da…
This table compares the peptides with actual PE-related clinical data. | Peptide | Primary Mechanism | Evidence Quality | Typical IELT Extension (Mean) | Onset Time | Known Limitations | Professional Assessment ||—|—|—|—|—|—|| Me…
Tirzepatide 15mg 20.9% 52 lbs 5 days Weekly Dual GIP/GLP-1 agonist. Appetite suppression + insulin sensitization 40–50% GI events during titration Highest documented efficacy for 50+ lb targets. Dual mechanism offsets metabolic a…
Thymalin Thymic hormone restoration → enhanced pineal melatonin synthesis 5–10 mg SC every 48–72 hours for 10–20 doses 10–14 days for rhythm changes; peaks at 4–6 weeks Age-related phase shifts, ASPS in older adults, immune-relat…
Most peptide hair formulations make claims grounded in isolated in vitro data. Cellular activity in a petri dish. Without corresponding human efficacy trials. Our experience reviewing peptide research across dermatology and regen…
Every peptide mentioned here is available as a research-grade compound through Real Peptides' full peptide collection. We mean this sincerely: the purity and sequencing accuracy matter more in cessation protocols than in almost a…
Peptides are most plausible for subacute or chronic sciatica (lasting 6–12 weeks or longer) where conservative treatment has stalled. If your sciatica resolved 80% in the first month with physical therapy and NSAIDs, adding pepti…
Tirzepatide (dual GLP-1/GIP) Incretin receptor agonist. Slows gastric emptying, enhances insulin sensitivity, suppresses appetite via hypothalamic signaling 20.9% mean body weight reduction at 72 weeks (SURMOUNT-1, n=2,539). High…
FOXO4-DRI Disrupts FOXO4-p53 interaction, restoring p53-mediated apoptosis in senescent cells High. 70% senescent cell death vs <5% in proliferating cells (2017 Cell study) Strong. Phase 1 human data published 2020 7–14 days for …
BPC-157 VEGF upregulation, collagen deposition, FAK-paxillin pathway modulation 10 mcg/kg daily (rodent studies) 28 days refrigerated; degrades 40% in 7 days at room temp No human pharmacokinetic data; subcutaneous bioavailabilit…
BPC-157 VEGF upregulation, FAK-paxillin pathway activation All phases (acute through remodelling) 250–500 mcg SC twice daily Moderate (animal models, limited human trials) Strongest evidence for angiogenesis and collagen organisa…
Before applying any peptide protocol, understand the mechanism it targets and the stage of miniaturisation where it's most effective. Early-stage androgenetic alopecia (Norwood I–III) responds better to stem cell activators; adva…
BPC-157 VEGF upregulation, angiogenesis, fibroblast migration to injury sites 250–500 mcg/day subcutaneous injection 7–14 days (pain reduction); 4–6 weeks (functional improvement) Animal studies robust; human data limited to case…
BPC-157 VEGF upregulation, anti-inflammatory cytokine modulation, fibroblast migration Inflammatory phase (weeks 0–6) 250–500mcg daily Subcutaneous (local or systemic) Animal models + case series (no RCTs) Strongest anti-inflamma…
Before comparing specific compounds, understand that peptide selection should align with the phase of healing and the specific tissue systems involved. Knee replacement surgery disrupts bone, cartilage, synovial membrane, ligamen…
GHK-Cu (Copper Tripeptide) Stimulates dermal papilla proliferation, increases VEGF expression Topical (requires <500 Da molecular weight formulation) Strong. 6/8 RCTs positive, mean 12–17% density increase at 12–16 weeks 1.0–1.5m…